Clinical Cancer Research AACR Conference on Cancer Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hibi, K.
Right arrow Articles by Nakao, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hibi, K.
Right arrow Articles by Nakao, A.
Clinical Cancer Research Vol. 7, 469-472, March 2001
© 2001 American Association for Cancer Research


Advances in Brief

AIS Overexpression in Advanced Esophageal Cancer

Kenji Hibi1, Hiroshi Nakayama, Masumi Taguchi, Yasushi Kasai, Katsuki Ito, Seiji Akiyama and Akimasa Nakao

Second Department of Surgery, Nagoya University School of Medicine, Nagoya 466-8550, Japan

We examined AIS status in digestive tract cancers and found that all eight esophageal cancer cell lines (100%) showed AIS/TA-AIS gene overexpression, whereas 1 of 12 (8%) gastric cancer and 0 of 14 (0%) colon cancer cell lines showed AIS/TA-AIS gene expression. We then confirmed that the AIS gene, not the TA-AIS gene, was dominantly expressed in esophageal cancers by reverse transcription-PCR. AIS protein was also expressed in AIS gene-positive cell lines. Subsequently, we tested AIS gene expression in paired esophageal normal tissues and cancers. Twenty-five of 39 (64%) primary esophageal cancers demonstrated an obviously higher expression of AIS gene compared to paired normal tissues. Moreover, high AIS gene expression was significantly associated with lymph node metastases in esophageal cancer (P = 0.0271). These results suggested that AIS may be useful as a marker for advanced esophageal cancer.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
K. Hibi, S.-i. Fujitake, T. Takase, Y. Kodera, K. Ito, S. Akiyama, M. Shirane, and A. Nakao
Identification of S100A2 as a Target of the {Delta}Np63 Oncogenic Pathway
Clin. Cancer Res., September 15, 2003; 9(11): 4282 - 4285.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Koike, K. Hibi, Y. Kasai, K. Ito, S. Akiyama, and A. Nakao
Molecular Detection of Circulating Esophageal Squamous Cell Cancer Cells in the Peripheral Blood
Clin. Cancer Res., September 1, 2002; 8(9): 2879 - 2882.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.